Zhou, Chun
Wang, Yun
Huang, Yikun
An, Yongpan
Fu, Xian https://orcid.org/0000-0001-9044-8850
Yang, Daqian
Wang, Yilin
Zhang, Jintao
Mitchell, Leslie A.
Bader, Joel S. https://orcid.org/0000-0002-6020-4625
Cai, Yizhi https://orcid.org/0000-0003-1663-2865
Dai, Junbiao
Boeke, Jef D. https://orcid.org/0000-0001-5322-4946
Cai, Zhiming
Xie, Zhengwei https://orcid.org/0000-0001-9572-878X
Shen, Yue https://orcid.org/0000-0002-3276-7295
Huang, Weiren https://orcid.org/0009-0001-6635-187X
Article History
Received: 19 March 2024
Accepted: 31 October 2024
First Online: 22 November 2024
Competing interests
: J.B. is a Founder and Director of CDI Labs, Inc., a Founder of and consultant to Neochromosome, Inc, a Founder, SAB member of and consultant to ReOpen Diagnostics, LLC and serves or served on the Scientific Advisory Board of the following: Sangamo, Inc., Logomix, Inc., Modern Meadow, Inc., Rome Therapeutics, Inc., Sample6, Inc., Tessera Therapeutics, Inc., and the Wyss Institute. The remaining authors declare no competing interests.